All DCIS is not the same: Young women and African American women at higher risk after DCIS diagnosis
Full article: https://oncology.jamanetwork.com/article.aspx?articleid=2427491
Diagnoses of ductal carcinoma in situ (DCIS), sometimes called stage 0 breast cancer, have increased in recent decades. Many people with DCIS wonder if they need aggressive treatment. A study looking at the survival of over 100,000 women found that breast cancer mortality after DCIS is low (3%), and identified groups of women who are at higher risk after DCIS. (9/8/15)
The National Comprehensive Cancer Network (NCCN) guidelines include the following options for treatment of DCIS:
- Breast-conserving therapy (lumpectomy followed by radiation therapy) without lymph node surgery.
- Total mastectomy with or without lymph node surgery.
- Breast-conserving surgery without lymph node surgery followed by accelerated partial breast irradiation.
- Breast-conserving surgery without lymph node surgery (and without radiation therapy).
Following surgery, the NCCN recommends that patients:
- Consider endocrine therapy for 5 years for people with ER-positive DCIS who:
- received breast conservation and radiation therapy.
- were treated with surgical excision only.
- Receive counseling regarding risk reduction.
Questions To Ask Your Health Care Provider
- What are the best options for treating my DCIS given my age and/or family background?
- Will my family history of cancer affect my treatment options for DCIS?
- What other tests can be used to help decide how to treat my DCIS?
- I was diagnosed with DCIS before age 50, should I consider genetic counseling or testing?
- What are my options for preventing a recurrence?
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.